Drug Shortage Report for APO-IRBESARTAN/HCTZ

Last updated on 2017-04-24 History
Report ID 351
Drug Identification Number 02387654
Brand name APO-IRBESARTAN/HCTZ
Common or Proper name IRBESARTAN/HCTZ
Company Name APOTEX INC
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01
Estimated end date 2017-04-30
Actual end date 2017-04-21
Shortage status Resolved
Updated date 2017-04-24
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-04-24 French Compare
v3 2017-04-24 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare